ARID4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.240560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.908800E-01
Normal-vs-Stage2
1.391360E-01
Normal-vs-Stage3
5.451700E-02
Normal-vs-Stage4
9.657200E-01
Stage1-vs-Stage2
6.567400E-01
Stage1-vs-Stage3
6.958500E-02
Stage1-vs-Stage4
3.511000E-01
Stage2-vs-Stage3
9.400000E-02
Stage2-vs-Stage4
1.046970E-01
Stage3-vs-Stage4
3.100400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.272170E-01
Normal-vs-AfricanAmerican
3.263800E-01
Normal-vs-Asian
8.292500E-02
Caucasian-vs-AfricanAmerican
9.881600E-01
Caucasian-vs-Asian
1.584820E-01
AfricanAmerican-vs-Asian
4.322000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.140760E-01
Normal-vs-Female
1.548360E-01
Male-vs-Female
9.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.610000E-01
Normal-vs-Age(41-60Yrs)
3.132600E-01
Normal-vs-Age(61-80Yrs)
8.538000E-02
Normal-vs-Age(81-100Yrs)
3.837600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.934400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.286600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.582240E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.577700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.566000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.513400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.288400E-02
Normal-vs-Daily Drinker
2.769500E-02
Normal-vs-Weekly Drinker
1.435210E-01
Normal-vs-Occasional Drinker
1.780580E-01
Normal-vs-Social Drinker
3.346800E-01
Non Drinker-vs-Daily Drinker
3.282000E-01
Non Drinker-vs-Weekly Drinker
6.840400E-01
Non Drinker-vs-Occasional Drinker
3.606600E-01
Non Drinker-vs-Social Drinker
3.862800E-01
Daily Drinker-vs-Weekly Drinker
7.513600E-01
Daily Drinker-vs-Occasional Drinker
8.651600E-02
Daily Drinker-vs-Social Drinker
1.365230E-01
Weekly Drinker-vs-Occasional Drinker
3.168800E-01
Weekly Drinker-vs-Social Drinker
3.706600E-01
Occasional Drinker-vs-Social Drinker
9.191400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.740200E-02
Normal-vs-Grade 2
1.445960E-02
Normal-vs-Grade 3
9.522300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.795020E-01
Grade 1-vs-Grade 3
6.441900E-02
Grade 1-vs-Grade 4
5.740200E-02
Grade 2-vs-Grade 3
3.760600E-01
Grade 2-vs-Grade 4
1.445960E-02
Grade 3-vs-Grade 4
9.522300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.055800E-02
Normal-vs-NonDiabetic
5.979700E-02
Diabetic-vs-NonDiabetic
9.452000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.475680E-02
Normal-vs-NoPancreatitis
7.933600E-02
Pancreatitis-vs-NoPancreatitis
8.841600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.724410E-01
Normal-vs-N1
1.276760E-01
N0-vs-N1
8.348600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.700000E-01
Normal-vs-TP53-NonMutant
2.907800E-01
TP53-Mutant-vs-TP53-NonMutant
9.261400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
